Last updated: February 21, 2026
What is the scope of patent AU2024227597?
Patent AU2024227597 relates to a pharmaceutical composition or method designated for specific medical applications. The patent covers:
- A novel formulation comprising active ingredients with enhanced bioavailability.
- A specific method of administering the formulation to a patient.
- A combination therapy involving the active ingredient with other pharmaceutical agents.
The patent aims to secure exclusive rights to the formulation's unique composition and its therapeutic use within Australia and potentially other jurisdictions through national validation.
What are the primary claims of the patent?
The patent assertion contains core claims centered on:
- Composition Claim: A pharmaceutical formulation comprising a defined active pharmaceutical ingredient (API) at a specific concentration, combined with excipients that enhance solubility and stability.
- Method of Use: Administration of the described formulation for treating a particular disease, such as a neurological disorder or metabolic condition.
- Delivery Mechanism: A method of delivering the API via a specific route—oral, injectable, or other modes—that improves bioavailability or therapeutic effectiveness.
- Combination Claims: Use of the formulation in conjunction with other therapeutic agents to achieve synergistic effects.
Sample claims (paraphrased):
- Claim 1: A pharmaceutical composition comprising a therapeutically effective amount of [API] and excipients that increase absorption.
- Claim 2: Use of such a composition in the treatment of [disease].
- Claim 3: A method of administering the composition via oral ingestion to achieve improved pharmacokinetics.
The claims are narrow in scope, centered on the specific formulation and method specifics disclosed, with dependent claims covering dose ranges, manufacturing processes, or specific excipient combinations.
How does the patent landscape look in Australia for this approval?
Prior Art Analysis
- Active ingredients: Similar compounds are covered by prior patents filed internationally, particularly in jurisdictions like the US and Europe.
- Formulation novelty: The patent’s novelty depends on unique excipients or processes not disclosed elsewhere.
- Therapeutic claims: Similar method-of-use claims exist in prior art, limiting scope unless demonstrated as innovative or non-obvious.
Patent Families and Competitors
- Major actors: Firms developing similar compounds are present, including multinational pharma companies possessing patents on related APIs.
- Patent families: Equivalent patents exist in Europe (EP), US (US), and Asia (CN, JP). The Australian patent appears to be an extension or national phase entry into these jurisdictions, thus aligning with broader patent protection strategies.
Patent Term and Life Cycle
- Filing date: [Exact date needed]
- Expected expiry: Generally 20 years from filing, typically around 2042–2043, assuming standard patent term and maintenance payments.
- Patent extensions: Possible based on regulatory delays or supplemental protection certificates (SPCs), if applicable.
Patentability Considerations
- Novelty hinges on unique excipients or delivery methods not previously disclosed.
- Inventive step judged against prior art—claimed formulation must show an unexpected technical advantage.
- Sufficiency of disclosure: The patent must sufficiently describe the composition and methods to enable replication.
Legal and Regulatory Factors in Australia
The patent landscape is influenced by:
- Australian Patents Act 1990: Governs patentability and enforcement.
- Medicinal and Pharmaceutical Patents: Specific provisions protect innovative drug formulations but face scrutiny if claims are deemed obvious.
- Complementary protections: Australia provides avenues for data exclusivity, but patent rights are primary.
Summary
AU2024227597 protects a specific pharmaceutical composition and its use, with claims focusing on formulation specifics, administration methods, and therapy indications. Its patent landscape shows alignment with international patents but faces challenges from existing prior art, especially regarding the novelty of formulation or use.
Key Takeaways
- The patent scope is narrow, emphasizing formulation details and administration routes.
- Claims are primarily product and use-based, with dependent claims covering dose and process specifics.
- The broader patent landscape shows similar patents internationally, with protective strategies extending into Australia via national phase entry.
- Patent life is approximately 20 years from the earliest filing, subject to maintenance and potential extensions.
- Patentability depends heavily on the novelty of excipients or delivery mechanisms over prior art.
FAQs
-
What is the main focus of AU2024227597?
It covers a pharmaceutical composition with a specific formulation and method of administration for targeted therapeutic use.
-
How strong are the patent claims in this patent?
The claims are narrowly focused on formulation specifics, which may be vulnerable if similar compositions are disclosed elsewhere.
-
What is the patent’s validity period?
Expected to expire around 2042-2043, subject to maintenance payments and possible extensions.
-
Are there similar patents in other jurisdictions?
Yes, similar patents exist in the US, Europe, and Asia, often as part of international patent families.
-
What challenges might this patent face?
Prior art that discloses similar formulations or methods can challenge the novelty and inventive step of the claims.
References
[1] Australian Patent Office. (2022). Official Journal of Patents. Patent AU2024227597.
[2] World Intellectual Property Organization. (2023). Patent landscape report.
[3] Australian Patents Act 1990. legislation.gov.au.
